Medical Xpress

DECEMBER 20, 2022

Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease (CAD) to better measure clinically important characterizations of the disease.

Development 145

Development Medicine Research Cardiology 145

Scienmag

FEBRUARY 17, 2021

Credit: Mark Bauer/FSU College of Medicine Nearly a half-million people a year die from sudden cardiac death (SCD) in the U.S. — the result of malfunctions in the heart’s electrical system.

Medicine 55

Medicine Genetic Disease Development Genetics 55

BioPharma Reporter

MAY 23, 2023

Neurimmune has announced that primary results of its phase 1 proof-of-concept study of NI006, a recombinant human antibody to deplete amyloid deposits in ATTR cardiomyopathy, have been presented in Prague at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC), and published in The New England Journal of Medicine.

Cardiology 52

Cardiology Antibody Medicine Development 52

Scienmag

APRIL 22, 2021

of the Division of Cardiovascular Medicine, Department of Internal Medicine) have developed an AI that uses multiple kinds of test data to predict the location of surplus pathways in the heart called ‘accessory pathways’, which cause the heart […].

Development 85

Development Medicine Cardiology Engineer 85

Rethinking Clinical Trials

JULY 19, 2023

Distinguished Professor of Medicine Professor of Nursing Duke University Neha J. This was a cluster-randomized trial of 42 cardiology clinics across the U.S., The cardiology clinics were randomized to one of two groups.     Speaker Christopher B. Granger, MD Donald F. Fortin, M.D.

Trials 130

Trials Cardiology Medicine Nurses 130

Drug Discovery World

AUGUST 7, 2023

Evox Therapeutics has agreed a research collaboration and option agreement with the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) in New York, NY, US. The collaboration will work on developing exosome-encapsulated AAV (exoAAV) vectors as a novel gene delivery technology aimed at improving treatments for heart disease.

Gene Therapy 52

Gene Therapy Gene Research In-Vivo 52

Scienmag

NOVEMBER 13, 2020

Smidt Heart Institute Chair of Cardiology presents new findings at American Heart Association Scientific Sessions Credit: Photo by Cedars-Sinai LOS ANGELES (Nov.

Cardiology 85

Cardiology Development Research Medicine 85

The Pharma Data

MARCH 23, 2022

Baynes, head of Global Clinical Development (GCD) and Chief Medical Officer, Merck Research Laboratories (MRL), will be retiring from Merck in July. Under his leadership, Merck has become a leading oncology company and achieved more than 140 medicine and vaccine approvals globally across numerous therapeutic areas.

Clinical Development 52

Clinical Development Development Vaccination Vaccine 52

Drug Discovery World

FEBRUARY 21, 2023

The conclusions are based on analysis of the most extensive datasets in the United States by a team from the Icahn School of Medicine at Mount Sinai. Researchers have revealed that vaccination against Covid-19 is associated with fewer heart attacks, strokes, and other cardiovascular issues among people who were infected with SARS-CoV-2.

Vaccination 52

Vaccination Vaccine Cardiology Medicine 52

Scienmag

OCTOBER 18, 2020

Beijing, China 19 Oct 2020: Elevated birth weight is linked with developing atrial fibrillation later in life, according to research presented at the 31st Great Wall International Congress of Cardiology (GW-ICC). Faculty from the European Society of Cardiology (ESC) will participate in joint scientific […].

Cardiology 43

Cardiology Development Research Medicine 43

Medical Xpress

DECEMBER 7, 2022

Mann Department of Biomedical Engineering have developed a "heart attack on a chip," a device that could one day serve as a testbed to develop new heart drugs and even personalized medicines. Researchers at the University of Southern California Alfred E.

Engineer 105

Engineer Medicine Development Drugs 105

Medical Xpress

MAY 11, 2023

An algorithm developed using artificial intelligence could soon be used by doctors to diagnose heart attacks with better speed and accuracy than ever before, according to new research from the University of Edinburgh published in Nature Medicine.

Doctors 98

Doctors Doctor Medicine Development 98

Scienmag

JUNE 27, 2021

Sophia Antipolis – 28 June 2021: A study in more than 200,000 individuals has found that patients with heart failure are more likely to develop cancer compared to their peers without heart failure.

Cardiology 40

Cardiology Development Research Medicine 40

The Pharma Data

DECEMBER 12, 2020

We look forward to welcoming our new colleagues at Alexion so that we can together build on our combined expertise in immunology and precision medicines to drive innovation that delivers life-changing medicines for more patients.” ” Ludwig Hantson , Ph.D., Strategic rationale.

Development 75

Development Regulation Medicine Containment 75

The Pharma Data

JANUARY 12, 2021

The data could help doctors diagnose and treat athletes recovering from COVID-19 who have developed myocarditis, an inflammation of the heart. Chung is an electrophysiologist and sports cardiologist at Michigan Medicine and member of the Big Ten Cardiac Registry Steering Committee. She is on the steering committee for the registry.

Cardiology 52

Cardiology Medicine Doctors Doctor 52

The Pharma Data

OCTOBER 31, 2020

With that in mind, the American College of Cardiology came up with some safety recommendations in May, which have now been revised. How many athletes with COVID-19 develop heart problems isn’t known, but the group said those who have moderate to severe coronavirus symptoms should be screened. 26 in JAMA Cardiology.

Cardiology 52

Cardiology Medicine Development 52

Velocity Clinical Research

DECEMBER 6, 2023

In addition to being one of Poland’s top recruiting sites in cardiology trials, ClinMedica also recruits patients across a broad range of therapeutic areas involving ambulatory medicine. About Grzegorz Kania, MD Grzegorz Kania, MD specializes in cardiology as well as internal and family medicine. and Europe.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

Scienmag

APRIL 20, 2021

Researchers at Penn Medicine uncover more genetic mutations that predispose women to peripartum cardiomyopathy, with implications for the future of increased genetic testing PHILADELPHIA– Researchers at Penn Medicine have identified more genetic mutations that strongly predispose younger, otherwise healthy women to peripartum cardiomyopathy (PPCM), (..)

Genetics 45

Genetics Development Medicine Research 45

FDA Law Blog

FEBRUARY 21, 2022

Unger, who is a 1971 recipient of the Rensselaer Polytechnic Institute Mathematics and Science Medal, earned a Bachelor of Science (magna cum laude) in chemistry from Wright State University in Dayton, Ohio, and a Doctor of Medicine from the University of Cincinnati College of Medicine in Cincinnati, Ohio.

Drugs 40

Drugs Cardiology FDA Approval Doctors 40

Medical Xpress

APRIL 17, 2023

A KAIST research team led by Professor Keon Jae Lee from the Department of Materials Science and Engineering and the College of Medicine of the Catholic University of Korea has developed a highly sensitive, wearable piezoelectric blood pressure sensor.

Engineer 84

Engineer Medicine Development Research 84

Medical Xpress

MAY 17, 2023

Using sophisticated modeling techniques, University of Maryland School of Medicine (UMSOM) researchers have developed a new tool that can predict the risk of heart disease in those over 40 based on their total exposure, through the years, to heart disease risk factors.

Medicine 101

Medicine Research Development Cardiology 101

The Pharma Data

FEBRUARY 24, 2022

An efficient intervention assessed by UACR reduction may provide long-term benefits for patients,” said Rajiv Agarwal, MD, Professor of Medicine, Indiana University School of Medicine and VA Medical Centre, Indianapolis, USA and Chair of the study’s Steering Committee. “If

Clinical Development 52

Clinical Development Development Cardiology Life Science 52

The Pharma Data

JUNE 28, 2021

The approval is based on the results of the pivotal Phase III VICTORIA trial, published in The New England Journal of Medicine (NEJM) in March 2020. Vericiguat is being jointly developed with MSD (a tradename of Merck & Co., The vericiguat program is being co-developed by Bayer and MSD. Verquvo (vericiguat) 2.5

Cardiology 52

Cardiology Production Development Medicine 52

The Pharma Data

SEPTEMBER 29, 2021

Heerspink, Professor of Clinical Trials and Personalized Medicine and a clinical pharmacologist/trialist at the Department of Clinical Pharmacy and Pharmacology at the University center Groningen, Netherlands, and Co-Chair of the study’s Executive Committee. The Bayer brand stands for trust, reliability and quality throughout the world.

Clinical Development 52

Clinical Development Development Clinical Trials Clinical Trials 52

Scienmag

NOVEMBER 19, 2020

Department of Molecular Pharmacology, Shinshu University School of Medicine, Japan Researchers have identified a new druggable target for heart failure in neonates and infants, a condition for which there has been no specific treatment. Credit: Mitsuhiko Yamada MD, PhD.,

Medicine 97

Medicine Drugs Development Research 97

Scienmag

MARCH 11, 2021

Credit: Dr Maik Pietzner at the MRC Epidemiology Unit A new study published today in Nature Medicine has identified key risk factors that increase the likelihood of individuals developing not only one but multiple non-communicable diseases, which include cardiovascular disease, cancer, chronic respiratory disease and diabetes.

Medicine 93

Medicine Development Cardiology 93

Scienmag

OCTOBER 8, 2020

ACC leaders will also present on management of acute coronary syndrome during conference The American College of Cardiology’s (ACC) Hani Najm Global Scholar Awards program was announced at the opening session of the Saudi Heart Association Annual Conference on Oct.

Cardiology 40

Cardiology Development Medicine 40

The Pharma Data

FEBRUARY 21, 2022

At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business, which is aimed at delivering long-term, sustainable business growth by bringing forward new options for patients. “We

Radiology 52

Radiology Cardiology Development Production 52

Scienmag

JULY 22, 2021

New USDA-NIFA funding brings together research, academics, and Extension to improve knowledge, access, and self-monitoring skills for hypertension management Credit: Edwin Remsberg, University of Maryland To address the significant health burden of hypertension (characterized by consistently high blood pressure), the University of Maryland (UMD) was (..)

Development 93

Development Research Cardiology Medicine 93

The Pharma Data

MARCH 13, 2022

(NYSE: PFE) announced today the completion of its acquisition of Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases. Additional Transaction Details.

Dermatology 52

Dermatology Cardiology Development Medicine 52

ACRP blog

JANUARY 24, 2023

Raising Community Awareness to Optimize Impact Nevada’s first integrated health system was created in June 2021 when an affiliation agreement was signed between Renown Health and the University of Nevada, Reno, School of Medicine. Significant progress was achieved.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

Scienmag

JULY 16, 2021

A scientific review has found evidence that a disruption in blood clotting and the first line immune system could be contributing factors in the development of psychosis.

Medicine 73

Medicine Development Research Allergies 73

Scienmag

MARCH 8, 2021

Identifies people at high risk of heart attack despite average LDL cholesterol levels Rome, Italy, March 8, 2021 – Allelica, a leading genomics software company specialising in developing polygenic risk scores (PRS) for personalised medicine, today announced publication of a study in Circulation (Vol.

Genome 75

Genome Genomics Medicine Development 75

Velocity Clinical Research

JANUARY 3, 2024

In my new role as Vice President Corporate Development (CEE) and Medical Director (CEE) together with my expertise of building out a site network, I intend to support the development of Velocity in Poland and in Europe more widely.” About Marek Konieczny, MD, PhD Dr. Konieczny is a specialist in cardiology and internal medicine.

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Research Trials 52

The Pharma Data

OCTOBER 14, 2020

. “I was so frustrated forcing these yucky and sticky syrup medicines into my son when he was sick. Now, we have a large pipeline of gummy drugs in development, from allergy and pain relief medications to fever reducers and cough suppressants. We are here to solve these problems.”

Drugs 52

Drugs Allergies Cardiology Drug Delivery 52

The Pharma Data

OCTOBER 27, 2021

Dietz MD, Professor of Genetic Medicine at The Johns Hopkins University School of Medicine in the United States, will join the Board of the Company as a Non-Executive Director. Dr Dietz completed his BS at Duke University and received his MD from the SUNY Upstate School of Medicine. Dr Hal Dietz is Victor A.

Genetics 52

Genetics Medicine Cardiology Scientist 52

Scienmag

JUNE 17, 2021

Tools for clinicians in point-of-care use UTICA, NY — More than 2 million coronary artery stents are implanted each year to help protect or restore normal blood flow to the heart, to treat patients suffering from angina or a heart attack due to coronary artery disease (CAD). While stents are highly effective and safe devices, […].

Research 72

Research Development Clinical Trials Clinical Trials 72